# Appfolio Inc: financial statements, quarterly

APPF · Nasdaq · CIK 1433195 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/appf.md) · [Financials](/companies/appf/financials.md) · [Filings](/companies/appf/filings.md) · [Insiders](/companies/appf/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/appf/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [172 d](/filings/0001433195-26-000011.md) | [187](/filings/0001433195-25-000055.md) | [197](/filings/0001433195-25-000105.md) | [206](/filings/0001433195-25-000142.md) | [204 d](/filings/0001433195-26-000011.md) | [218](/filings/0001433195-26-000023.md) | [236](/filings/0001433195-26-000058.md) | [249](/filings/0001433195-26-000064.md) | [248 d](/filings/0001433195-26-000011.md) | [262](/filings/0001433195-26-000023.md) | [281](/filings/0001433195-26-000058.md) | [296](/filings/0001433195-26-000064.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Research and development | $m | [34.8 d](/filings/0001433195-26-000011.md) | [37.9](/filings/0001433195-25-000055.md) | [39.5](/filings/0001433195-25-000105.md) | [40.7](/filings/0001433195-25-000142.md) | [42.3 d](/filings/0001433195-26-000011.md) | [43.8](/filings/0001433195-26-000023.md) | [46.7](/filings/0001433195-26-000058.md) | [54.0](/filings/0001433195-26-000064.md) | [46.0 d](/filings/0001433195-26-000011.md) | [49.6](/filings/0001433195-26-000023.md) | [51.0](/filings/0001433195-26-000058.md) | [53.1](/filings/0001433195-26-000064.md) |
| Operating income | $m | [28.2 d](/filings/0001433195-26-000011.md) | [34.1](/filings/0001433195-25-000055.md) | [36.0](/filings/0001433195-25-000105.md) | [42.6](/filings/0001433195-25-000142.md) | [23.0 d](/filings/0001433195-26-000011.md) | [33.8](/filings/0001433195-26-000023.md) | [40.5](/filings/0001433195-26-000058.md) | [35.0](/filings/0001433195-26-000064.md) | [43.6 d](/filings/0001433195-26-000011.md) | [50.7](/filings/0001433195-26-000023.md) | [53.0](/filings/0001433195-26-000058.md) | [57.4](/filings/0001433195-26-000064.md) |
| Income tax | $m | [0.7 d](/filings/0001433195-26-000011.md) | [(1.6)](/filings/0001433195-25-000055.md) | [9.8](/filings/0001433195-25-000105.md) | [13.6](/filings/0001433195-25-000142.md) | [(75.6) d](/filings/0001433195-26-000011.md) | [5.4](/filings/0001433195-26-000023.md) | [6.0](/filings/0001433195-26-000058.md) | [3.1](/filings/0001433195-26-000064.md) | [5.7 d](/filings/0001433195-26-000011.md) | [10.7](/filings/0001433195-26-000023.md) | [12.9](/filings/0001433195-26-000058.md) | [13.6](/filings/0001433195-26-000064.md) |
| Net income | $m | [30.3 d](/filings/0001433195-26-000011.md) | [38.7](/filings/0001433195-25-000142.md) | [29.7](/filings/0001433195-25-000142.md) | [33.0](/filings/0001433195-25-000142.md) | [103 d](/filings/0001433195-26-000011.md) | [31.4](/filings/0001433195-26-000064.md) | [36.0](/filings/0001433195-26-000064.md) | [33.6](/filings/0001433195-26-000064.md) | [39.9 d](/filings/0001433195-26-000011.md) | [42.4](/filings/0001433195-26-000064.md) | [41.5](/filings/0001433195-26-000064.md) | [46.0](/filings/0001433195-26-000064.md) |
| Diluted EPS | $ per share | not reported | [1.05](/filings/0001433195-25-000055.md) | [0.81](/filings/0001433195-25-000105.md) | [0.90](/filings/0001433195-25-000142.md) | not reported | [0.86](/filings/0001433195-26-000023.md) | [0.99](/filings/0001433195-26-000058.md) | [0.93](/filings/0001433195-26-000064.md) | not reported | [1.18](/filings/0001433195-26-000023.md) | [1.17](/filings/0001433195-26-000058.md) | [1.29](/filings/0001433195-26-000064.md) |
| Basic EPS | $ per share | not reported | [1.07](/filings/0001433195-25-000055.md) | [0.82](/filings/0001433195-25-000105.md) | [0.91](/filings/0001433195-25-000142.md) | not reported | [0.86](/filings/0001433195-26-000023.md) | [1.00](/filings/0001433195-26-000058.md) | [0.94](/filings/0001433195-26-000064.md) | not reported | [1.19](/filings/0001433195-26-000023.md) | [1.17](/filings/0001433195-26-000058.md) | [1.30](/filings/0001433195-26-000064.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: not reported
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [49.5](/filings/0001433195-26-000011.md) | [59.2](/filings/0001433195-25-000055.md) | [59.6](/filings/0001433195-25-000105.md) | [62.4](/filings/0001433195-25-000142.md) | [42.5](/filings/0001433195-26-000011.md) | [56.9](/filings/0001433195-26-000023.md) | [73.5](/filings/0001433195-26-000058.md) | [76.1](/filings/0001433195-26-000064.md) | [107](/filings/0001433195-26-000064.md) | [147](/filings/0001433195-26-000023.md) | [217](/filings/0001433195-26-000058.md) | [259](/filings/0001433195-26-000064.md) |
| Current assets | $m | [272](/filings/0001433195-25-000013.md) | [307](/filings/0001433195-24-000054.md) | [349](/filings/0001433195-24-000106.md) | [395](/filings/0001433195-24-000127.md) | [335](/filings/0001433195-26-000011.md) | [272](/filings/0001433195-25-000055.md) | [197](/filings/0001433195-25-000105.md) | [303](/filings/0001433195-25-000142.md) | [353](/filings/0001433195-26-000064.md) | [255](/filings/0001433195-26-000023.md) | [325](/filings/0001433195-26-000058.md) | [407](/filings/0001433195-26-000064.md) |
| Total assets | $m | [409](/filings/0001433195-25-000013.md) | [439](/filings/0001433195-24-000054.md) | [479](/filings/0001433195-24-000106.md) | [523](/filings/0001433195-24-000127.md) | [627](/filings/0001433195-26-000011.md) | [565](/filings/0001433195-25-000055.md) | [567](/filings/0001433195-25-000105.md) | [640](/filings/0001433195-25-000142.md) | [689](/filings/0001433195-26-000064.md) | [581](/filings/0001433195-26-000023.md) | [648](/filings/0001433195-26-000058.md) | [716](/filings/0001433195-26-000064.md) |
| Current liabilities | $m | [69.8](/filings/0001433195-25-000013.md) | [56.1](/filings/0001433195-24-000054.md) | [63.3](/filings/0001433195-24-000106.md) | [63.7](/filings/0001433195-24-000127.md) | [63.3](/filings/0001433195-26-000011.md) | [58.6](/filings/0001433195-25-000055.md) | [67.6](/filings/0001433195-25-000105.md) | [100](/filings/0001433195-25-000142.md) | [107](/filings/0001433195-26-000064.md) | [72.4](/filings/0001433195-26-000023.md) | [84.9](/filings/0001433195-26-000058.md) | [102](/filings/0001433195-26-000064.md) |
| Total liabilities | $m | [112](/filings/0001433195-25-000013.md) | [99.6](/filings/0001433195-24-000054.md) | [108](/filings/0001433195-24-000106.md) | [110](/filings/0001433195-24-000127.md) | [107](/filings/0001433195-26-000011.md) | [103](/filings/0001433195-25-000055.md) | [112](/filings/0001433195-25-000105.md) | [142](/filings/0001433195-25-000142.md) | [146](/filings/0001433195-26-000064.md) | [110](/filings/0001433195-26-000023.md) | [122](/filings/0001433195-26-000058.md) | [133](/filings/0001433195-26-000064.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [297](/filings/0001433195-26-000011.md) | [339](/filings/0001433195-25-000142.md) | [371](/filings/0001433195-25-000142.md) | [413](/filings/0001433195-25-000142.md) | [519](/filings/0001433195-26-000064.md) | [462](/filings/0001433195-26-000064.md) | [456](/filings/0001433195-26-000064.md) | [499](/filings/0001433195-26-000064.md) | [543](/filings/0001433195-26-000064.md) | [470](/filings/0001433195-26-000064.md) | [526](/filings/0001433195-26-000064.md) | [583](/filings/0001433195-26-000064.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [31.2 d](/filings/0001433195-26-000011.md) | [43.0](/filings/0001433195-25-000055.md) | [50.9 d](/filings/0001433195-25-000105.md) | [57.8 d](/filings/0001433195-25-000142.md) | [36.6 d](/filings/0001433195-26-000011.md) | [38.5](/filings/0001433195-26-000023.md) | [52.6 d](/filings/0001433195-26-000058.md) | [86.0 d](/filings/0001433195-26-000064.md) | [65.0 d](/filings/0001433195-26-000011.md) | [34.3](/filings/0001433195-26-000023.md) | [87.6 d](/filings/0001433195-26-000058.md) | [96.8 d](/filings/0001433195-26-000064.md) |
| Capital expenditure | $m | [3.1 d](/filings/0001433195-26-000011.md) | [1.4](/filings/0001433195-25-000055.md) | [0.0 d](/filings/0001433195-25-000105.md) | [0.4 d](/filings/0001433195-25-000142.md) | [0.2 d](/filings/0001433195-26-000011.md) | [0.2](/filings/0001433195-26-000023.md) | [0.3 d](/filings/0001433195-26-000058.md) | [1.3 d](/filings/0001433195-26-000064.md) | [1.3 d](/filings/0001433195-26-000011.md) | [0.2](/filings/0001433195-26-000023.md) | [(0.0) d](/filings/0001433195-26-000058.md) | [0.0 d](/filings/0001433195-26-000064.md) |
| Share repurchases | $m | not reported | [0.0](/filings/0001433195-25-000055.md) | [0.0 d](/filings/0001433195-25-000105.md) | [0.0 d](/filings/0001433195-25-000142.md) | [0.0 d](/filings/0001433195-26-000011.md) | [95.8](/filings/0001433195-26-000023.md) | [50.0 d](/filings/0001433195-26-000058.md) | [0.0 d](/filings/0001433195-26-000064.md) | [0.0 d](/filings/0001433195-26-000011.md) | [125](/filings/0001433195-26-000023.md) | [0.0 d](/filings/0001433195-26-000058.md) | [4.2 d](/filings/0001433195-26-000064.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [35.4](/filings/0001433195-24-000054.md) | [35.6](/filings/0001433195-24-000106.md) | [36.5](/filings/0001433195-24-000127.md) | [36.7](/filings/0001433195-25-000055.md) | [36.7](/filings/0001433195-25-000105.md) | [36.8](/filings/0001433195-25-000142.md) | [36.6](/filings/0001433195-26-000023.md) | [36.2](/filings/0001433195-26-000058.md) | [36.3](/filings/0001433195-26-000064.md) | [35.8](/filings/0001433195-26-000023.md) | [35.5](/filings/0001433195-26-000058.md) | [35.6](/filings/0001433195-26-000064.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:39 ET. No prices; not investment advice.